tirzepatide patent expiry india With Ozempic in India, cheaper generics are rising, raising concerns about misuse, self-medication, and lack of proper medical supervision among users. Experts warn improper use of weight-loss drugs can cause India warns of misuse risk

Experimental Dermatology, 34 (2), e70042

Early data from the TRIUMPH trials is undeniably compelling, showing unprecedented weight loss of up to 28.7% at 68 weeks significantly outpacing tirzepatide in early comparisons (see our Retatrutide vs Tirzepatide comparison guide)

Obesity is associated with several other comorbidities, including psoriasis, which is a chronic autoimmune skin disease

Funding This research was supported by the Beijing Natural Science Foundation (6212009), and the Reform and Development Project of Beijing Academy of Agricultural and Forestry Sciences (XMS202411)

There is no forced live-video-only requirement